Pharma Legal and Compliance Summit 2015


Friday, October 16, 2015


Debolina Partap, VP, legal & general counsel, Wockhardt Group, Summit Chair, PLCS 2015; Arshad Jamil, senior director legal, Biocon; Arun Parikh, Sr. VP (Legal), Cadila Healthcare Ltd.


The Leela
Sir Mathuradas Vasanji Rd, Greater Indra Nagar, Andheri East -


Bhupinder Kaur M: +91-9654155065 E: T: 01166569793


9 am-6 pm

Event Type:

The Indian pharmaceuticals market is third largest in terms of volume and 13th largest in terms of value, as per a pharmaceuticals sector analysis report by equity master. The market is dominated majorly by branded generics which constitute nearly 70 to 80 percent of the market. Considered to be a highly fragmented industry, consolidation has increasingly become an important feature of the Indian pharmaceutical market. India has achieved an eminent global position in pharma sector. The country also has a huge pool of scientists and engineers who have the potential to take the industry to a very high level.